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ur eyes are our window to the world, but
for many people the view becomes dim
or even darkens entirely due to visual
impairment. Although the full impact of the envi-
ronment on sight is unknown and significant gaps
remain in our understanding of vision disorders,
many reports have shown that low vision and
blindness can be directly or indirectly related to
environmental exposures.
Vision is described in terms of visual acuity
and field of vision. Visual acuity is a measure of
how well an individual sees compared with some-
one with normal sight—for example, a person
with 20/60 vision must be within 20 feet of an
object to see it as clearly as a normal-sighted per-
son at 60 feet—and a normal field of vision is 160
to 170 degrees. 
The World Health Organization (WHO) esti-
mates that approximately 124 million people have
low vision, which it defines as visual acuity
between 20/60 and 20/400 with the best possible
correction or a visual field of 20 degrees or less.
Another 37 million people meet the WHO defini-
tion for blindness, which is visual acuity that can-
not be corrected to better than 20/400 or a visual
field of 10 degrees or less. An analysis published in
the April 2004 Archives of Ophthalmology by the
Eye Disease Prevalence Research Group, a consor-
tium representing several institutions, indicates
that low vision or blindness affects 3.3 million
Americans over age 40 and predicts that this fig-
ure may be as high as 5.5 million by 2020. (In this
study, low vision was defined as visual acuity
between 20/40 and 20/200 with best correction,
while blindness was defined as visual acuity of
20/200 or worse with best correction.)
According to the WHO, the rising trend is
likely to be seen globally as well. An expanding
population explains some of the increase, but
more critically, the fastest-growing population
sector comprises people older than 50. World-
wide, more than 80% of people who are blind
are 50 or older, although they represent only
19% of the world’s population. Gender is also
significantly associated with visual impairment.
Women represent two-thirds of those with
blinding eye disease, even after controlling for
women’s longer life spans. 
Risk also varies by race, ethnicity, and world
region. Socioeconomic development often pre-
dicts regional prevalence of a disorder. Of the
approximately 1.4 million children with blindness
in the world, about 75% live in high-poverty areas
in Asia and Africa. Among children in high- and
middle-income countries, optic nerve defects,
other neurological problems, and retinopathy of
prematurity (a consequence of incomplete eye
development) are the most common causes of
blindness. 
Developing nations are disproportionately
affected due in large part to the burdens associated
with poverty: lack of clean water and sanitation,
limited or nonexistent health care, and malnutri-
tion. Among children in low-income countries,
vision problems arise mostly from complications
of measles or rubella, nutritional deficiency,
improper or inadequate treatment, and eye infec-
tions in the first days of life. In Tibet, an area
with one of the highest prevalences of cataract, a
lack of vitamin A is compounded by exposure to
high-altitude ultraviolet (UV) light, soot and
pathogens from indoor burning of coal and yak
dung, and a dusty, windy environment. As a
result, 10.9% of the total Tibetan population suf-
fers visual impairment.
Cataract
The primary insult to the eye is age, and one very
common result of aging is cataract, in which the
lens acquires color and may also become clouded
or opaque. “If you live long enough, you will get
cataract,” says Roger Truscott, an associate profes-
sor and senior research fellow at the Save Sight
Institute at the University of Sydney in Australia.
Non–age-related cataract arises from specific
mutations in membrane proteins, injury, toxic or
infectious exposures, and diabetes. Family studies
have shown that genetics has a role in heritable
cataract and may influence the development of
age-related cataract, although no specific genes
have been identified. 
Cataract ranks as the leading cause of blind-
ness and low vision worldwide. The WHO esti-
mates that nearly 48% of global blindness arises
from cataract. Cataract removal is one of the most
common surgeries in the United States, with
approximately 1 million operations performed
each year. In developing countries, cataract can
mean permanent blindness because sight-restor-
ing treatment is unavailable or unaffordable for
many people.
Among the suspected environmental contribu-
tors to age-related cataract are UV light exposure,
cigarette smoking, and a diet low in antioxidants.
Natalie Kurinij, program director of the NEI
Vision Research Program, cites results published
over the years from the Chesapeake Bay Waterman
Study and the Salisbury Eye Evaluation Project as
supportive evidence of the risk presented by UV
exposure. “We’re fairly confident that sunlight
exposure plays a role,” says Kurinij.
That role seems to be linked to oxidative dam-
age, which follows the generation of free radicals.
The same sort of mechanism is suspected with
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Smoking generates free radicals throughout
the body, and those may be responsible for
lens damage. The precise mechanisms by
which oxidative damage to the lens occurs are
still being investigated.
The relationship between free radicals
and lens damage may not be direct, however.
“The epidemiological data are surprisingly
weak when you think that our eyes are
exposed for about half of our lifetime, and it
seems to make sense that a transparent tissue,
designed to transmit light, should suffer
ultraviolet damage,” says Truscott. The lens
possesses a good UV filter system, but it
decreases with age. Further, the lens’s ability
to maintain low oxygen levels within its cen-
ter also seems to diminish, and the lens thus
becomes more susceptible to oxidative dam-
age. Due to these changes in the lens, the
compounds that serve as UV filters may bind
to lens proteins, which then become more
sensitive to UV radiation–induced damage. 
A diet rich in free radical–scavenging
antioxidants might be protective,
but proof is lacking. “Vitamin
data are not convincing with
regard to cataract, but [vitamins]
E and C could be useful. There’s
still much more to know,” says
Truscott. Kurinij agrees that sup-
port for nutrition’s role varies.
“There have been conflicting
reports from observational studies
regarding the role of antioxidant
nutrients and the development of
cataract,” she says. “Any potential
effect of antioxidant nutrients on
cataract will probably depend on
the nutritional status of the popu-
lation to begin with.” 
To illustrate the complexity of
researching dietary effects on
vision, Kurinij compares random-
ized clinical trial results from the
NEI’s Age-Related Eye Disease
Study to cataract studies conduct-
ed in Linxian, China. In the NEI
study, high-dose antioxidant and
zinc supplements over a six-year
period was not associated with
lens opacities in a healthy, well-
nourished U.S. population. How-
ever, in the relatively nutritionally
deprived Linxian subjects a multi-
vitamin supplement or a supple-
ment with riboflavin and niacin
was associated with fewer cases of
cataract. 
Oxidative damage also fig-
ures in research conducted by
Debra Schaumberg, a clinical
associate scientist at Schepens
Eye Research Institute and an
assistant professor of medicine
and ophthalmology at Harvard
Medical School. Schaumberg
and her colleagues reported in
the April 1999 issue of the
Annals of Epidemiology that peo-
ple with higher blood levels of
C-reactive protein, an indicator
of systemic inflammation, had a
higher incidence of cataract.
“This was really the first time
that anyone had shown that
systemic inflammation, with no clinically
detectable inflammation in the eye,
increased the risk of cataract,” says
Schaumberg, who notes that older people
and obese persons tend to have higher lev-
els of inflammatory activity in the body.
“Obesity is one of the strongest contribu-
tors to the levels of something like C-reac-
tive protein,” she says. 
Schaumberg also identifies heavy metal
exposure as a risk factor needing more
research. According to a study led by
Schaumberg and published in the 8 Decem-
ber 2004 issue of JAMA, low-level lead
exposure appears linked to cataract forma-
tion in men. Of 642 men ranging in age
from 48 to 93 years, 122 were diagnosed
with cataract. Bone scans determined that
the men’s long-term, low-level lead exposure
was comparable to that of the general popu-
lation. Men in the highest exposure group
(8.17–35.0 micrograms per deciliter) had
2.5 times the risk of having cataract as the
men in the lowest exposure group (1.0–3.0
micrograms per deciliter). “As far as we
know, this paper . . . was really the only epi-
demiological study looking at heavy metals
in relation to eye disease. I think it’s really an
area that we don’t know much about,” she
says.
At the opposite end of the age spec-
trum, children may have cataract at birth or
develop the condition in infancy due to
prenatal infection with rubella or toxoplas-
mosis, among other causes. Such cases need
immediate treatment. One consequence of
untreated cataract is nystagmus, any of a
variety of involuntary movements of the
eyes. Amblyopia, or “lazy eye,” is another
condition found in children. “In the first
weeks up until the first couple of months [of
life], if vision is disturbed in both eyes that
then will cause poor vision for the rest of life
because nystagmus cannot be treated in any
way,” says Jill Keeffe, an associate professor
at the Centre for Eye Research Australia.
“With cataract, it needs to be treated within
weeks, whereas with amblyopia, which
might develop from strabismus [drifting or
crossing of one or both eyes] or from uneven
refractive error between the two eyes, the
window of opportunity is much longer.
Obviously, the earlier, the better.”
Retinal Disorders
Retinal disorders also pose a threat world-
wide. Age-related macular degeneration
(AMD) refers to damage to the area of the
retina responsible for sharp central vision. It
is the third most common global cause of
blindness, accounting for approximately
8.7% of total blindness, and the primary
cause of blindness in developed countries. In
the United States, there are approximately
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Clouding our vision. Cataract, the leading cause of blind-
ness worldwide, arises from a combination of factors
including genetics, age, and environmental exposures.
Though largely treatable, poor access to health care leaves
many around the world to suffer. (Top to bottom) An acute
sudden-onset cortical cataract in a person with type 1 dia-
betes; a hypermature age-related cataract; a white con-
genital cataract.Environmental Health Perspectives • VOLUME 113 | NUMBER 12 | December 2005 A 825
1.8 million people with vision loss due to
AMD, and another 7.3 million are at risk. As
the average age of the world’s population
creeps upward, AMD will become even more
significant. 
As much as 30% of AMD may be relat-
ed to smoking. A prospective study published
in the 9 October 1996 issue of JAMA linked
smoking with AMD, and more recently a
study in the 14 April 2005 British Journal of
Ophthalmology showed that smokers were
twice as likely as nonsmokers to develop
AMD. The risk declines if one stops smok-
ing, to the point that after 20 years of not
smoking former smokers have about the
same level of risk as nonsmokers. Possible
mechanisms of damage linked to smoking
include depressed levels of antioxidants,
reduced oxygen, and altered blood flow. 
The effect of diet on AMD risk shares
some of the same components as cataract;
specifically, low-level antioxidant levels may
heighten the chances of developing the dis-
ease. Obesity and high blood pressure, fat
intake, and cholesterol levels also appear to
increase AMD risk, but the specifics are not
yet clear.
Family studies imply a genetic link,
which is supported by three papers published
in the 15 April 2005 issue of Science and a
fourth published in the 2 May 2005 issue of
Proceedings of the National Academy of
Sciences. “Age-related macular degeneration is
certainly a disease that’s affected by our
genes,” says Timothy Stout, an associate pro-
fessor of ophthalmology at the Casey Eye
Institute in Portland, Oregon. “What’s inter-
esting is that it’s also a disease that’s influ-
enced by our environment. The link between
those two has been puzzling in the past, and
I think there are new studies that suggest that
some of the genes that play a role in the
development of macular degeneration are
genes that may be involved in inflammation
and our immune response.” 
In early 2005, the four teams independ-
ently associated AMD with a gene coding for
complement factor H, an inflammatory
component. “The recent research implicating
the complement factor H gene in AMD is a
major breakthrough,” says Peter Humphries,
a professor of medical molecular genetics at
Trinity College in Dublin, Ireland. “Many
studies have resulted in localizing so-called
susceptibility genes to chromosomal regions,
but the studies recently reported are the first
to identify an actual gene. I expect that we
will find out a great deal more about the so-
called molecular pathology of AMD as a
result of this discovery.” 
Further, up to six regions within the
genome have been implicated as potentially
harboring AMD genes, and a second gene
was reported in the November 2005 Human
Molecular Genetics. “As yet we have very little
information about this most recent gene,”
says Humphries. “[However], once more is
known about the mechanisms of action of
such variants, we stand to know a lot more
about the cause of AMD, and hence the
prospects for eventual prevention will
become more realistic.”
Retinal damage is also a hallmark of dia-
betic retinopathy, which blinds about 5 mil-
lion people worldwide. The U.S. Centers for
Disease Control and Prevention estimates
that 13.8 million Americans have been diag-
nosed with diabetes and another 5.2 million
have it without realizing it. Duration of dia-
betes and its control affect risk of diabetic
retinopathy, and approximately 5.3 million
Americans over age 18 have the eye condi-
tion. With diabetes rates increasing, in part
due to increasing obesity, diabetic retinopa-
thy can be expected to become more preva-
lent. Dietary and genetic factors may also
affect its development, as may high blood
pressure and high cholesterol. 
“All of these things—hypertension, dia-
betes, hypercholesterolemia—tend to have
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Insight into the problem. Flies attracted to eye secretions are one way
trachoma is transmitted (above). In its bid to eradicate this disease by
2020, the WHO encourages facial cleanliness (right top) and improve-
ments in sanitation such as burying waste (right bottom). bad effects at the level of the small blood ves-
sels, the capillaries,” says Stout. Retinal vein
blockages associated with high cholesterol,
high triglycerides, and high blood pressure
can create capillary-bursting pressure. The
tissue then becomes hypoxic, or insuffi-
ciently oxygenated. Retinal hypoxia also
occurs in diabetes when the capillary net-
work dies through mechanisms that are not
completely clear. 
Hypoxia triggers production of vascular
endothelial growth factor, which promotes
formation of new blood vessels, but the
process is disorganized. “The body tends to
not build the blood vessels in the right
place, so they will grow not as nicely
formed capillaries in the retina, but at the
optic nerve or into the center part of the eye
or at the part of the eye where the drainage
system is, and that causes all sorts of prob-
lems,” says Stout. Further, the poorly built
new vessels leak, as may existing blood ves-
sels. Ultimately, the retina detaches from
the underlying layers, and vision is lost. 
Infections and Nutritional
Deficiencies
Slightly more than 5% of global blindness
arises from injury- or disease-associated
corneal opacity. Distinct from this category,
trachoma accounts for an additional 3.6% of
global blindness. Trachoma is the most com-
mon infectious cause of vision loss and
affects approximately 84 million people, pri-
marily in remote rural areas of Africa, Asia,
Central and South America, Australia, and
the Middle East. This disorder arises from
repeated infection by Chlamydia trachomatis
bacteria that are spread by close contact with
an infected person or by flies. After numer-
ous infections, eyelid scarring turns the eye-
lashes inward, and they rake against the
cornea, a condition called trichiasis. The irri-
tation scars the cornea and eventually ren-
ders it opaque.
Infection typically starts in childhood,
although the blinding effects do not occur
until well into adulthood. “It’s not just one
infection—it’s repeated infections,” says
Keeffe. “We’ve seen scarring in the lids of
preschool-aged children, . . . but it’s usually
not until the forties and fifties that vision
loss occurs.” In some areas, 60–90% of pre-
school-age children carry active infections.
Women account for 75% of late-stage
blinding trachoma cases, possibly because
they have greater contact with children. 
In 1997 the WHO launched GET
(Global Elimination of Trachoma) 2020
with the goal of eradicating trachoma alto-
gether. A major part of GET 2020 is a pri-
mary health care plan known as the SAFE
strategy. The SAFE strategy utilizes lid sur-
gery (S), antibiotics (A) to treat active infec-
tions, facial cleanliness (F), and environ-
mental changes (E) geared toward improv-
ing sanitation and access to clean water. A
review of the SAFE strategy published in the
June 2003 issue of The Lancet Infectious
Diseases found strong support for the use of
antibiotics and surgery in warding off infec-
tion and blindness, although the evidence
for face washing and environmental im-
provements was weaker.
Onchocerciasis, also known as river
blindness, is caused by Onchocerca volvulus,
a parasite transmitted by blackflies in river-
side areas. The disease is endemic in West
and Central Africa, Yemen, and several
South American countries. When a blackfly
bites, a juvenile form of the parasite enters
the body. Once mature, females release
high numbers of larvae that migrate to the
skin and eyes. Associated lesions form in all
eye tissues except for the lens, and lead to
inflammation, bleeding, secondary infec-
tions, and eventually blindness. More than
17 million people are infected with the par-
asite, approximately 500,000 people are
visually impaired as a result, and another
250,000 are blind. Fear of infection pre-
vents arable riverside land from being used,
and local economic growth stagnates. 
Global efforts at halting river blindness
started with effective vector control efforts
in 1974, and ongoing community-based
treatment with ivermectin, an antiparasite
medication, began in 1996. The disease has
been reduced in most areas and may be
eradicated from Latin America by 2010. 
Among children, cornea-clouding vita-
min A deficiency is the most common cause
of preventable childhood blindness. Poor
night vision is the key symptom of the very
early stages of the corneal damage preceding
blindness. At this stage, children can retain
their vision with repeated doses of vitamin
A. In late-stage vitamin A deficiency, the
cornea becomes very white and cloudy, and
vision loss is irreparable; cornea transplants
are impossible because the tissue becomes
too damaged. Immunization and good
nutrition are key to preventing this form of
blindness, but where these interventions are
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Focusing on onchocerciasis. When parasites spread by blackflies (above) enter the
body, their larvae migrate to the eyes and skin, causing lesions that result in inflam-
mation, bleeding, and severe visual impairment or blindness if left untreated treat-
ed (right top). Treatment with ivermectin (right bottom) has reduced the disease in
most areas and nearly eradicated it in some.Environmental Health Perspectives • VOLUME 113 | NUMBER 12 | December 2005 A 827
not immediately possible, doses of vitamin
A make “lovely primary health interven-
tions,” says Keeffe. In addition to supplying
vitamin A supplements, health organiza-
tions also strongly promote vitamin A–rich
diets. Breastfeeding provides ample vitamin
A to babies, and older children and adults
receive the nutrient through garden produce
and supplemented foods.
An Eye to the Future
The WHO estimates that up to 75% of all
blindness is preventable. Vision 2020: The
Right to Sight, a program instituted in
1999 by the WHO and the International
Agency for the Prevention of Blindness,
builds upon previous programs, dovetails
with pre-existing efforts of many organiza-
tions, identifies remaining regional and
national needs, and provides a framework
for filling gaps. Through Vision 2020, a
coordinated effort is under way to eliminate
preventable blindness by 2020 by increas-
ing awareness of eye disease, garnering
resources for prevention and treatment,
controlling major causes of avoidable blind-
ness, training ophthalmologists and other
eye care personnel to diagnose and treat the
diseases specific to certain regions, and pro-
viding these specialists with necessary tech-
nology and infrastructure. 
Other organizations also have carried
out large-scale international programs. For
example, Lions Clubs International, a serv-
ice organization with a long history of com-
bating low vision and blindness, instituted
the worldwide SightFirst program with
three major goals: treating and preventing
diseases such as river blindness, trachoma,
and cataract; providing education and
training of health care workers to diagnose
and treat eye disease; and constructing and
equipping health care facilities. The group
is currently building SightFirst II as well as
collaborating with the WHO on the
Project for the Elimination of Avoidable
Childhood Blindness. 
On a national level, the U.S. government
sponsors prevention and treatment through
the Department of Health and Human
Services’ Healthy Vision 2010 and the NEI’s
National Eye Health Education Program.
Healthy Vision 2010 is part of Health
People 2010, a national program to improve
the health of Americans, and seeks to pro-
mote regular eye examinations for adults and
children, vision screening for preschoolers,
and injury prevention. There’s also a compo-
nent to educate people with low vision about
treatment. The National Eye Health Edu-
cation Program has a more specific focus,
encouraging early detection and treatment
of glaucoma and diabetic eye disease, and
providing education about treatment for low
vision. This program provides materials that
communities can use to educate the public
about eye disease and the importance of
early detection and treatment.
A critical gap in eliminating preventable
blindness and low vision is delivery of
health care. Without access to health care,
opportunities are missed to diagnose prob-
lems early when treatment is most likely to
be successful. Access to health care is a
problem in many nations, including the
United States. Stout offers diabetes as an
example of the United States falling short
in this regard. “That’s a huge population
problem for us in the United States,
because as people are falling through the
health care cracks and aren’t [controlling
diabetes] they’re going to get very signifi-
cant blinding diabetic retinopathy at a rela-
tively early age,” he says. “Vision loss in
anybody is not a good thing, but vision loss
in a relatively young, healthy person who
presumably has a productive career ahead
of them—it’s a real issue.” 
For all that’s been learned about eye dis-
ease, there remain gaps, and new hypothe-
ses continue to be generated. Researchers at
the Schepens Eye Research Institute recent-
ly embarked on the $2.2 million, three-year
Planning Grant for Research on Blinding
Eye Diseases. Like other NIH “roadmap”
grants, this one is designed to promote
interdisciplinary collaborations regarding
complex health challenges. “While experts
from these areas often collaborate informal-
ly on [eye] disease, ophthalmology has
remained somewhat specialized and in
some ways isolated from other disciplines,”
remarked Darlene Dartt, director of scien-
tific affairs at Schepens Eye Research
Institute, in announcing the grant. “This is
really the first federal program to formalize
collaboration.” In learning more about the
cascade of events occurring in other parts of
the body in diseases ranging from
Alzheimer disease to rheumatoid arthritis,
researchers might gain some insight into
the processes of blinding eye diseases. 
Julia R. Barrett
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Seeing a way past trachoma. A 15-minute procedure performed by a doc-
tor or trained nurse using local anesthetic can reverse the conditions that cause
trachoma and reduce the risk of blindness. Globally, however, lack of access to
basic health care keeps many patients in the dark.